cytidine diphosphate choline has been researched along with Infarction, Middle Cerebral Artery in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ballesteros, I; Camarero, G; Cuartero, MI; Hernández-Jiménez, M; Hurtado, O; Lizasoain, I; Moraga, A; Moro, MA; Pradillo, JM; Zarruk, JG | 1 |
| Agulla, J; Al-Soufi, W; Argibay, B; Blanco, M; Brea, D; Campos, F; Castillo, J; Ramos-Cabrer, P; Sobrino, T | 1 |
| Alkan, T; Korfali, E; Sahin, S; Temel, SG; Tolunay, S; Tureyen, K | 1 |
| Agulla, J; Argibay, B; Castillo, J; Pérez-Mato, M; Ramos-Cabrer, P | 1 |
| Chen, H; Han, H; Hou, C; Li, W; Xia, Z | 1 |
| Alvarez-Grech, J; Díez-Tejedor, E; Expósito-Alcaide, M; Fuentes, B; Gutiérrez-Fernández, M; Rodríguez-Frutos, B; Vallejo-Cremades, MT | 1 |
| Ataus, SA; Balkan, S; Locke, KW; Onal, MZ; Ozdem, SS | 1 |
| Chen, XL; Kang, QY; Liu, JX; Liu, Y; Qiu, F; Tian, YF; Zhang, PB; Zhao, JJ | 1 |
| Alonso de Leciñana, M; Carceller, F; Díez-Tejedor, E; Gutiérrez, M; Roda, JM | 1 |
| Alborch, E; Castillo, J; Fernández-López, D; Hurtado, O; Lizasoain, I; Morales, JR; Moro, MA; Pradillo, JM; Sobrino, T | 1 |
| Clark, WM; Gammans, RE; Sabounjian, LA; Selzer, KA; Williams, BJ; Zweifler, RM | 1 |
| Barrachina, M; Ferrer, I; Krupinski, J; Lozano, R; Mercadal, J; Secades, JJ | 1 |
1 trial(s) available for cytidine diphosphate choline and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
A randomized efficacy trial of citicoline in patients with acute ischemic stroke.
Topics: Aged; Algorithms; Cytidine Diphosphate Choline; Double-Blind Method; Female; Humans; Infarction, Middle Cerebral Artery; Logistic Models; Male; Nootropic Agents; Odds Ratio | 1999 |
11 other study(ies) available for cytidine diphosphate choline and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Citicoline (CDP-choline) increases Sirtuin1 expression concomitant to neuroprotection in experimental stroke.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzamides; Blotting, Western; Brain Ischemia; Cells, Cultured; Cytidine Diphosphate Choline; Drug Synergism; Infarction, Middle Cerebral Artery; Male; Mice; Mice, Knockout; Monocytes; Naphthols; Neurons; Neuroprotective Agents; Nootropic Agents; Rats; Rats, Inbred F344; Resveratrol; Sirtuin 1; Stilbenes; Stroke | 2013 |
In vivo theranostics at the peri-infarct region in cerebral ischemia.
Topics: Animals; Biomarkers; Cells, Cultured; Cytidine Diphosphate Choline; HSP72 Heat-Shock Proteins; Infarction, Middle Cerebral Artery; Liposomes; Magnetic Resonance Imaging; Male; Microscopy, Fluorescence; Nanocapsules; Nootropic Agents; Optical Imaging; Proteome; Rats; Rats, Sprague-Dawley | 2013 |
Effects of citicoline used alone and in combination with mild hypothermia on apoptosis induced by focal cerebral ischemia in rats.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Biomarkers; Brain; Brain Infarction; Brain Ischemia; Combined Modality Therapy; Cytidine Diphosphate Choline; Disease Models, Animal; Hypothermia, Induced; Immunohistochemistry; Infarction, Middle Cerebral Artery; Male; Nerve Degeneration; Neurons; Neuroprotective Agents; Nootropic Agents; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Treatment Outcome | 2010 |
Serial MRI study of the enhanced therapeutic effects of liposome-encapsulated citicoline in cerebral ischemia.
Topics: Animals; Brain; Brain Ischemia; Cerebral Infarction; Cytidine Diphosphate Choline; Disease Models, Animal; Dose-Response Relationship, Drug; Infarction, Middle Cerebral Artery; Injections, Intraperitoneal; Injections, Intravenous; Liposomes; Magnetic Resonance Imaging; Male; Nootropic Agents; Rats; Rats, Sprague-Dawley; Stroke | 2011 |
Simple diffusion delivery via brain interstitial route for the treatment of cerebral ischemia.
Topics: Animals; Brain Ischemia; Cytidine Diphosphate Choline; Diffusion; Infarction, Middle Cerebral Artery; Magnetic Resonance Imaging; Male; Nootropic Agents; Rats; Rats, Sprague-Dawley | 2011 |
CDP-choline treatment induces brain plasticity markers expression in experimental animal stroke.
Topics: Animals; Apoptosis; Biomarkers; Blotting, Western; Brain Chemistry; Brain Ischemia; Cell Proliferation; Cytidine Diphosphate Choline; Glial Fibrillary Acidic Protein; Immunohistochemistry; In Situ Nick-End Labeling; Infarction, Middle Cerebral Artery; Magnetic Resonance Imaging; Male; Neuronal Plasticity; Nootropic Agents; Rats; Rats, Sprague-Dawley; Stroke; Synaptophysin; Vascular Endothelial Growth Factor A | 2012 |
The effects of citicoline and lamotrigine alone and in combination following permanent middle cerebral artery occlusion in rats.
Topics: Analysis of Variance; Animals; Anticonvulsants; Brain; Brain Ischemia; Cerebral Infarction; Cytidine Diphosphate Choline; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Therapy, Combination; Infarction, Middle Cerebral Artery; Lamotrigine; Male; Neurologic Examination; Random Allocation; Rats; Rats, Wistar; Statistics, Nonparametric; Tetrazolium Salts; Treatment Outcome; Triazines | 2004 |
[Effect of citicoline on spatial learning and memory of rats after focal cerebral ischemia].
Topics: Animals; Avoidance Learning; Cytidine Diphosphate Choline; Infarction, Middle Cerebral Artery; Male; Maze Learning; Nootropic Agents; Random Allocation; Rats; Rats, Sprague-Dawley; Spatial Behavior | 2006 |
Effect of combined therapy with thrombolysis and citicoline in a rat model of embolic stroke.
Topics: Animals; Brain Infarction; Cell Death; Cytidine Diphosphate Choline; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Fibrinolytic Agents; Immunohistochemistry; In Situ Nick-End Labeling; Infarction, Middle Cerebral Artery; Interleukin-6; Male; Neurologic Examination; Neuroprotective Agents; Rats; Rats, Long-Evans; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Tumor Necrosis Factor-alpha | 2006 |
Delayed post-ischemic administration of CDP-choline increases EAAT2 association to lipid rafts and affords neuroprotection in experimental stroke.
Topics: Animals; Cell Fractionation; Cytidine Diphosphate Choline; Disease Models, Animal; Excitatory Amino Acid Transporter 2; Gene Expression Regulation; Glutamic Acid; Infarction, Middle Cerebral Artery; Male; Membrane Microdomains; Neuroprotective Agents; Rats; Rats, Inbred F344; Time Factors | 2008 |
CDP-choline reduces pro-caspase and cleaved caspase-3 expression, nuclear DNA fragmentation, and specific PARP-cleaved products of caspase activation following middle cerebral artery occlusion in the rat.
Topics: Animals; Blotting, Western; Caspase 3; Caspase Inhibitors; Caspases; Cell Nucleus; Cytidine Diphosphate Choline; DNA Fragmentation; Enzyme Precursors; Female; Hydrolysis; Infarction, Middle Cerebral Artery; Injections, Intraperitoneal; Nootropic Agents; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Rats; Rats, Sprague-Dawley; Substrate Specificity | 2002 |